PRIOR PRINTER'S NO. 584

PRINTER'S NO. 1804

THE GENERAL ASSEMBLY OF PENNSYLVANIA

SENATE BILL

No.

511

Session of

2021

INTRODUCED BY J. WARD, FONTANA, ARGALL, COLLETT, VOGEL, MARTIN,

PHILLIPS-HILL, PITTMAN, YUDICHAK, HUTCHINSON, MENSCH, BAKER,

BROWNE, STEFANO, MUTH, AUMENT, HAYWOOD, STREET, SANTARSIERO,

of pharmacy, including the sales, use and distribution of

drugs and devices at retail; and amending, revising,

consolidating and repealing certain laws relating thereto,"

further providing for authority to administer injectable

medications, biologicals and immunizations.

AMENDING THE ACT OF SEPTEMBER 27, 1961 (P.L.1700, NO.699),

ENTITLED "AN ACT RELATING TO THE REGULATION OF THE PRACTICE

OF PHARMACY, INCLUDING THE SALES, USE AND DISTRIBUTION OF

DRUGS AND DEVICES AT RETAIL; AND AMENDING, REVISING,

CONSOLIDATING AND REPEALING CERTAIN LAWS RELATING THERETO,"

(P.L.1700, No.699), known as the Pharmacy Act, is amended to

read:

Section 9.2. Authority to Administer Injectable Medications,

Biologicals and Immunizations.--[(a) The board shall by

regulation establish education and training standards and

practice guidelines pursuant to which pharmacists shall be

authorized to administer injectable medications, biologicals and

curriculum approved by the board that includes the current

guidelines and recommendations of the Centers for Disease

Control and Prevention in the Public Health Service of the

United States Department of Health and Human Services, the

American Council on Pharmaceutical Education or a similar health

authority or professional body and includes, but is not limited

to, disease epidemiology, vaccine characteristics, injection

technique, emergency response to adverse events and related

topics.

(2) Maintenance of a current cardiopulmonary resuscitation

authority approved by the board.

(4) That a minimum of two hours of the thirty-hour

requirement for continuing education for license renewal be

dedicated to this area of practice.

(5) For individuals under eighteen years of age, that

parental consent be obtained prior to administration.

Administration of influenza immunizations by injectable or

needle-free delivery methods shall be in accordance with the

disciplinary proceedings. The board shall accept as satisfactory

evidence of insurance coverage any of the following:

(i) personally purchased liability insurance;

(ii) professional liability insurance coverage provided by

the individual licensee's employer; or

(iii) similar insurance coverage acceptable to the board.

(7) Notification of the individual's primary care provider,

if known, within forty-eight hours of administration.]

(a.1) The board shall by regulation establish education and

training standards and practice guidelines pursuant to which

(i) A vaccine listed in the United States Centers for

Disease Control and Prevention's Recommended Immunization

Schedule recommended by the Federal Advisory Committee on

Immunization Practices; or

(ii) A vaccine recommended in the United States Centers for

Disease Control and Prevention's Health Information for

International Travel; or

(iii) A vaccine listed on the Food and Drug Administration's

curriculum approved by the board that includes the current

guidelines and recommendations of the Centers for Disease

Control and Prevention in the Public Health Service of the

United States Department of Health and Human Services, the

Accreditation Council for Pharmacy Education or a similar health

authority or professional body and includes, but is not limited

to, disease epidemiology, vaccine characteristics, injection

technique, emergency response to adverse events and related

topics.

(2) Registration with the board or certification as a

pharmacy education. The practical training program must include,

but is not limited to, hands-on injection technique and the

recognition and treatment of emergency reactions to vaccines.

(3) Acceptable proof of education and training standards as

evidenced by the immunization credentials or a license of an

individual who, at the time of filing an application is licensed

as a pharmacist and has immunization credentials or a license,

if applicable, in another state or territory of the United

Centers for Disease Control and Prevention, Advisory Committee

on Immunization Practices guidelines or another competent

authority approved by the board.

(6) That a minimum of two hours of the thirty-hour

requirement for continuing education for license renewal be

dedicated to this area of practice.

(7) For individuals under eighteen years of age, that

parental consent be obtained prior to administration.

Administration of influenza immunizations by injectable or

needle-free delivery methods shall be in accordance with the

insurance coverage as required shall subject the licensees to

disciplinary proceedings. The board shall accept as satisfactory

evidence of insurance coverage any of the following:

(i) personally purchased liability insurance;

(ii) professional liability insurance coverage provided by

the individual licensee's employer; or

(iii) similar insurance coverage acceptable to the board.

(9) Notification of the individual's primary care provider,

training which meets the requirements of subsection [(a)(1) and

(2)] (a.2)(1) and (4) and a pharmacy technician who meets the

requirements of subsection (a.2)(2) and (4) may administer

injectable medications, biologicals and immunizations to persons

who are more than eighteen years of age and [influenza] the

immunizations listed in subsection (a.1)(2) by injectable or

needle-free delivery methods to persons [nine] who are three

years of age and older only under the direct, immediate and

personal supervision of a pharmacist holding the authority to

administer injectable medications, biologicals and

(d) A pharmacist, pharmacy intern and pharmacy technician

who administers an immunization to a person under eighteen years

of age in accordance with this section shall inform the parent

or adult caregiver on the importance of a well-child visit with

a pediatrician or other licensed primary care provider and refer

the patient as appropriate.

(e) Nothing in this section shall be construed to prohibit a

supervising pharmacist from delegating the reporting of vaccine

Section 2. This act shall take effect in 60 days.

SECTION 1. SECTION 9.2(A) INTRODUCTORY PARAGRAPH AND (5) AND

(B) OF THE ACT OF SEPTEMBER 27, 1961 (P.L.1700, NO.699), KNOWN

AUTHORIZED TO ADMINISTER INJECTABLE MEDICATIONS, BIOLOGICALS AND

IMMUNIZATIONS TO PERSONS WHO ARE MORE THAN EIGHTEEN YEARS OF AGE

AND INFLUENZA AND COVID-19 IMMUNIZATIONS BY INJECTABLE OR

NEEDLE-FREE DELIVERY METHODS TO PERSONS [NINE] FIVE YEARS OF AGE

AND OLDER. SUCH STANDARDS AND GUIDELINES SHALL INCLUDE, BUT NOT

BE LIMITED TO, THE FOLLOWING:

* * *

(5) FOR INDIVIDUALS UNDER EIGHTEEN YEARS OF AGE, THAT

PARENTAL CONSENT BE OBTAINED PRIOR TO ADMINISTRATION.

ADMINISTRATION OF INFLUENZA AND COVID-19 IMMUNIZATIONS BY

BIOLOGICALS AND IMMUNIZATIONS SHALL NOT BE DELEGATED TO ANY

OTHER PERSON. A PHARMACY INTERN WHO HAS COMPLETED A COURSE OF

EDUCATION AND TRAINING WHICH MEETS THE REQUIREMENTS OF

ADMINISTER INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS

OR A PHYSICIAN, PHYSICIAN ASSISTANT OR CERTIFIED REGISTERED

NURSE PRACTITIONER.

(C) A SUPERVISING PHARMACIST SHALL REPORT THE

ADMINISTRATION OF IMMUNIZATIONS UNDER THIS SECTION TO THE

IMMUNIZATION REGISTRY MAINTAINED BY THE DEPARTMENT OF HEALTH

WITHIN SEVENTY-TWO HOURS OF IMMUNIZATION ADMINISTRATION AND TO

THE INDIVIDUAL'S PRIMARY CARE PROVIDER IN ACCORDANCE WITH

SUBSECTION (A)(7). NOTHING IN THIS SUBSECTION SHALL BE CONSTRUED

TO PROHIBIT A SUPERVISING PHARMACIST FROM DELEGATING THE

APPROPRIATE.

(E) A PHARMACIST WHO HOLDS THE AUTHORITY TO ADMINISTER

INJECTABLE MEDICATIONS, BIOLOGICALS AND IMMUNIZATIONS MAY

DELEGATE THE AUTHORITY TO ADMINISTER INFLUENZA AND COVID-19

IMMUNIZATIONS TO A CERTIFIED REGISTERED NURSE PRACTITIONER,

PHYSICIAN ASSISTANT, REGISTERED NURSE OR LICENSED PRACTICAL

NURSE.

SECTION 2. THE PROVISIONS OF 49 PA. CODE §§ 27.12(C)(1) AND

27.403(B) ARE ABROGATED INSOFAR AS THEY ARE INCONSISTENT WITH

THE AMENDMENT OR ADDITION OF SECTION 9.2(A) INTRODUCTORY

PARAGRAPH AND (5), (B), (C) AND (D) OF THE ACT.

SECTION 3. THIS ACT SHALL TAKE EFFECT IMMEDIATELY.